2019年北京國(guó)際細(xì)胞治療論壇暨臨床管理培訓(xùn)會(huì)日程

1、2019年北京國(guó)際細(xì)胞治療論壇暨臨床管理培訓(xùn)會(huì)日程主會(huì)場(chǎng)（5月18日上午）7：30-8：30報(bào)到時(shí)間Time內(nèi)容Content 講者/單位Speaker/ Institution8:30-8:40Opening remark 致辭大會(huì)主席 Chairman of the conference馬潔 Jie Ma北京醫(yī)院Beijing HospitalHongtao Liu 劉洪濤Assistant Professor of MedicineSection of Hematology / OncologyChicago University芝加哥大學(xué)血液腫瘤科8:40-9:10Haploident

2、ical transplantation: some concept, different results單倍體移植：一些觀點(diǎn)和不同結(jié)果黃曉軍 XiaoJun Huang北京大學(xué)血液病研究所所長(zhǎng)、北京大學(xué)人民醫(yī)院血液科主任Chairman, Peking University Institute of Hematology、Director, Department of Hematology, Peking University Peoples Hospital9:10-9:40the past, current and the future of stem cell transplant a

3、nd cellular therapy干細(xì)胞移植和細(xì)胞治療的過(guò)去，現(xiàn)在和將來(lái)Dr. Michael Bishop Professor of MedicineSection of Hematology / OncologyChicago University芝加哥大學(xué)血液腫瘤科9:40-10:10State-of-the art of treatment of ALL: molecular, antibody and cellular targeting to eradicate MRDALL治療新技術(shù)：分子，抗體和細(xì)胞靶向治療MRDDr. Wendy StockProfessor of Med

4、icineChicago University芝加哥大學(xué)10:10-10:30討論Discussion10:30-10:40茶歇 Tea break10:40-11:10腎細(xì)胞癌的免疫治療Immunotherapy for renal cell carcinoma龔侃 Kan Gong北京大學(xué)第一醫(yī)院Peking University First Hospital11:10-11:40實(shí)體腫瘤細(xì)胞治療臨床研究Clinical study in cellular immunotherapy for solid tumors馬潔 Jie Ma北京醫(yī)院Beijing Hospital11:40-12

5、:10前列腺癌免疫治療進(jìn)展Progress in immunotherapy for prostate cancer王偉 Wei Wang北京同仁醫(yī)院Beijing Tongren HospitalHematology血液學(xué)分會(huì)場(chǎng)（5月18日下午）（免費(fèi)參會(huì)）時(shí)間Time內(nèi)容Content講者/單位Speaker/ Institution13:30-13:40Opening remark 致辭13:40-14:10Donor-derived HCMV-specific T cells therapy for CMV infection post allogenic stem cell造血干細(xì)胞

6、移植后供者來(lái)源HCMV特異性T細(xì)胞治療巨細(xì)胞病毒感染Dr. Xiangyu Zhao 趙翔宇Section of hematology/Peking University Institute of Hematology北京大學(xué)人民醫(yī)院血液科、北京大學(xué)血液病研究所14:10-14:40Road to improve the outcomes of AML with poor gene mutation-experience from a single center如何提高不良基因突變的AML預(yù)后Dr. Daihong Liu 劉代紅Section of HematologyPLA First m

7、edical center (PLA 301 Hospital)解放軍總醫(yī)院第一醫(yī)學(xué)中心血液科14:40-15:10Discussion討論15:10-15:30Tea break 茶歇15:30-16:30Immunotherapies in Hematologic malignancies血液腫瘤的免疫治療Dr. Hongtao Liu 劉洪濤Assistant Professor of MedicineSection of Hematology / OncologyChicago University芝加哥大學(xué)血液腫瘤科16:00-16:30CD19CAR-T for treatment

8、 of B cell ALL Chinese experienceCD19CAR-T細(xì)胞治療B-ALL的中國(guó)經(jīng)驗(yàn)Dr. Peihua Lu 陸佩華Hematology of Lu Daopei Hospital陸道培醫(yī)院，血液.腫瘤科16:30-17:00The CART treatment for lymphomas淋巴瘤的CAR-T治療Dr. Peter RiedellAssistant Professor of MedicineSection of Hematology / OncologyChicago University芝加哥大學(xué)血液腫瘤科17:00-17:30Discussion

9、 討論Urology泌尿腫瘤分會(huì)場(chǎng)（5月18日下午）（免費(fèi)參會(huì)）時(shí)間Time內(nèi)容Content講者/單位Speaker/ Institution13:30-13:40致辭 Address龔侃 Kan Gong北京大學(xué)第一醫(yī)院Peking University First Hospital第一部分Part one主持嘉賓：李宏召 盧劍 畢新剛 Guest host: Hongzhao Li, Zheng li, Xingang Bi13:40-14:10泌尿系腫瘤免疫治療經(jīng)驗(yàn)分享Experience in immunotherapy of urinary tumors麥海星 Haixing Ma

10、i 解放軍第五醫(yī)學(xué)中心(原307醫(yī)院)PLA Fifth medical center (PLA 307 Hospital)14:10-14:40PSMA-PET在前列腺癌診療中的應(yīng)用Application of PSMA-PET in the diagnosis and treatment of prostate cancer張寧 Ning Zhang北京大學(xué)腫瘤醫(yī)院Beijing Cancer Hospital, Peking University14:40-15:10討論嘉賓：王偉 范欣榮 趙國(guó)華 蔡林 Discussion: Wei Wang, Xinrong Fan, Guohua

11、Zhao, Lin Cai15:10-15:30茶歇Tea break第二部分Part two主持嘉賓：張勇 張爭(zhēng) 王建偉Guest host: Yong Zhang, Jian Lu, Jianwei Wang15:30-16:00尿路上皮癌免疫治療的應(yīng)用Application of immunotherapy for urothelial carcinoma郝鋼躍 Gangyue Hao 北京友誼醫(yī)院Beijing Friendship Hospital16:00-16:30免疫不良反應(yīng)的處理Management of adverse immune reactions范欣榮 Xinrong

12、 Fan 北京協(xié)和醫(yī)院Peking Union Medical College Hospital16:30-17:00討論嘉賓：畢新剛 麥海星 楊奕 吳鵬杰Discussion: Xingang Bi, Haixing Mai, Yi Yang, Pengjie Wu 17:00-17:30總結(jié)Conclusion李宏召 解放軍第一醫(yī)學(xué)中心Hongzhao Li PLA first medical center (PLA 301 Hospital)臨床管理培訓(xùn)會(huì)分會(huì)場(chǎng)（5月18日下午）（注冊(cè)參會(huì)）時(shí)間Time內(nèi)容Content講者/單位Speaker/ Institution13:30-13:

13、40致辭 Address13:40-14:25腫瘤細(xì)胞免疫治療的原理與設(shè)計(jì)Principles and design of Cellular Immunotherapy of Cancer 韓為東Weidong Han解放軍總醫(yī)院第一醫(yī)學(xué)中心PLA First medical center (PLA 301 Hospital)14:25-15:10細(xì)胞治療臨床實(shí)驗(yàn)設(shè)計(jì)Clinical trial design for cellular therapy張毅 Yi Zhang鄭州大學(xué)第一附屬醫(yī)院The First Affiliated Hospital of Zhengzhou Universit

14、y15:10-15:20茶歇Tea break15:20-16:05實(shí)體瘤免疫治療思考與實(shí)踐Thinking and practice of solid tumor immunotherapy崔久巍 Jiuwei Cui吉林大學(xué)第一附屬醫(yī)院The First Affiliated Hospital of Jilin University16:05-16:50臨床試驗(yàn)過(guò)程控制及常見(jiàn)問(wèn)題Process control and common problems in clinical trials北京醫(yī)院Beijing Hospital16:50-17:35Choosing Gene Therapy

15、Clinical Trial Candidates: getting from gene selection to the bedside. 選擇基因治療臨床試驗(yàn)受試者:從基因選擇到臨床試驗(yàn)Martin E JayssonApexell Medicine臨床管理培訓(xùn)會(huì)分會(huì)場(chǎng)（5月19日上午）時(shí)間Time內(nèi)容Content講者/單位Speaker/ Institution8:30-8:40致辭 Address8:40-9:30細(xì)胞治療產(chǎn)業(yè)國(guó)家政策及分析National policy and analysis of cellular therapy industry國(guó)家衛(wèi)生健康委The 

16、National Health Commission9:30-10:20細(xì)胞藥物審評(píng)技術(shù)要求 Technical requirements for cellular drug evaluation國(guó)家藥品監(jiān)督管理局藥品審評(píng)中心Drug Evaluation Center of the State Food and Drug Administration10:20-11:10CAR-T細(xì)胞治療藥物監(jiān)管法規(guī)與質(zhì)量控制Regulations and quality control of Car-T cell therapeutic drugs中國(guó)食品藥品檢定研究院 生物制品檢定所Institute of Bio